Central regions | Technology & innovation

Researchers show how to step up cancer therapy efficacy

27 Feb '17
Researchers from Russia’s Moscow Lomonosov State University (MSU) and their Swedish colleagues have provided enough evidence to show that denying cancer cells access to nutrient substances could impact therapy both negatively and positively, depending on the type of an anti-tumor drug.

The scientists have published an English-language article on this research in Biochimica et Biophysica Acta – Molecular Cell Research.

Cancer cells grow very fast and need much energy to sustain growth, consuming glucose in much greater quantities than healthy cells. However, if there’s not enough glucose for them to feed on, some of the cancer cells begin devouring an amino acid called glutamine.

According to Vladimir Gogvadze, a senior research fellow at MSU’s apoptosis study laboratory, the international team has now proved that depending on different anti-tumor drugs, depriving cancer cells of access to glutamine can stimulate their death in some instances and prevent it in some others. So, it’s now clear that a physician should think twice before combining anti-tumor drug therapy with glutamine metabolism (TTFA mitochondrial complex II) inhibitors.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Moscow

Tags: cancer (63) / MSU (36) / anti tumor drug (1) / glutamine (0) /

Latest News: Central regions
17 Nov '17 | Technology & innovation
15 Nov '17 | Technology & innovation | Finance, business
14 Nov '17 | Finance, business | Transport, logistics
13 Nov '17 | Technology & innovation
9 Nov '17 | Finance, business

Feature stories

7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
20 Jun '17
In regions most of European Russians will hardly ever...
Search (News archive - 21190)
Marchmont News

Latest News

17 Nov '17
Three major Russian institutions—the Far East...
16 Nov '17
The Sverdlovsk Venture Fund in the Ural region...
15 Nov '17
Russia announced a new round of active support for...

Most read stories from last week

17 Nov '17
Three major Russian institutions—the Far East...